Rare diseases
Investigational molecules
Locations
VMX-C001 in Patients Taking Factor Xa Inhibitors Who Need Urgent Surgery or an Invasive Procedure With High Bleeding Risk
The NetherlandsDurvalumab and Chemotherapy in Adults With Muscle-Invasive Bladder Cancer
The NetherlandsAsciminib in Pediatric Patients With Philadelphia Positive Chronic Myeloid Leukemia in Chronic Phase
The NetherlandsJNJ-79635322 versus Teclistamab in Patients with Relapsed or Refractory Multiple Myeloma After at Least 3 Prior Treatments
The NetherlandsPumitamig Versus Pembrolizumab in Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%
The NetherlandsObrixtamig, Carboplatin, and Etoposide for First-Line Treatment of Advanced Extrapulmonary Neuroendocrine Carcinoma in DLL3-Positive Patients
The NetherlandsGB-0895 for Severe Uncontrolled Asthma in Adults and Adolescents
The NetherlandsA Study of BI 764532, Atezolizumab, Carboplatin, and Etoposide in Patients With Extensive-Stage Small Cell Lung Cancer
The NetherlandsComparison of Obicetrapib and Bempedoic Acid in Patients with Dyslipidemia at High to Very High Cardiovascular Risk
The NetherlandsEvaluation of pembrolizumab and bevacizumab in patients with metastatic cervical cancer
The NetherlandsPhase 3 Study of LY4170156 (Sofetabart Mipitecan) with drug combination in platinum‑resistant and platinum‑sensitive ovarian cancer patients
The NetherlandsRO7795068 for Weight Loss in Adults With Obesity or Overweight Without Type 2 Diabetes
The NetherlandsTell us about your condition – we search every trial in Europe and connect you with the right site.
